APRILLE MARQUEZ: Open Payments
NPI 1528228491 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 25 payments from 12 companies in 2025. Trend: 2023 $485 · 2024 $537 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $136 |
| Sumitomo Pharma America, Inc. | 2 | $98 |
| Lilly USA, LLC | 4 | $76 |
| Abbott Laboratories | 2 | $45 |
| Exact Sciences Corporation | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
Products named: GEMTESA, Wegovy, Ozempic, FREESTYLE LIBRE 3, MOUNJARO, JARDIANCE, Cologuard Collection Kit, TZIELD.
Industry payments across TX — which companies pay providers there.
